Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

Join-point regression analysis of the statistically significant linear increase in use of antidementia and antipsychotics during the observed time period. by Jelena Filimonovic (22305307)

Cephalometric measurement points. by Lijuan Liu (136685)

Point cloud fusion instance effect. by Hongliang Zou (20707270)

Subjects:

Join-point regression analysis of the statistically significant linear increase in use of anxiolytics, psychostimulants and noot ropic drugs, sedatives and hypnotics, gabapentinoids during the observed time period. by Jelena Filimonovic (22305307)

Join-point regression analysis of the statistically significant linear decrease in use of antidepressants, antipsychotics, psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics during the observed time period. by Jelena Filimonovic (22305307)

Stable isotope biplots of end-members (colored points) faceted by coastscape and overlayed consumers (gray points). by Nathan D. McTigue (10706460)

Schematic of calculation for the point load strength. by Hong Zhang (25820)

Subjects:

Selection of soil particle sampling points. by Xueting Ma (390540)

Comparison of PCNA expression grades across different groups at various time points. by Jian-feng Li (8667645)

Subjects:

Consecutive time points of data collection. by Martin Matzka (2636344)

“…Effect sizes expectedly decreased over time. Physical quality of life remained relatively constant over time and was the only outcome for which social integration on admission was not a significant prognostic factor.…”

Scaling of overall health burden with yearly expenditure growth. by Margherita Molaro (17803989)

Subjects:

Comparison of mTOR expression grading among different groups at different time points. by Jian-feng Li (8667645)

Subjects:

Comparison of all–age cases with age–standardized incidence, prevalence,deaths, and DALYs in global men and women, 1990–2021. by Zhengpeng Li (2322058)

Subjects:

Comparison of the number of incidence, prevalence, deaths and DALYs counts by age group and their crude ratios in China in 1990 and 2021. by Zhengpeng Li (2322058)

Subjects:

Comparison of ASIR, ASPR, ASMR and ASDR trends in China and global RA from 1990 to 2021. by Zhengpeng Li (2322058)

Subjects:

Global comparison of incidence, prevalence, deaths and DALYs counts by age group and their crude rates, 1990 and 2021. by Zhengpeng Li (2322058)

Subjects:

Comparison of all–age cases with age–standardized incidence, prevalence,deaths, and DALYs in Chinese men and women, 1990–2021. by Zhengpeng Li (2322058)

Subjects:

Comparison of RA incidence, prevalence, death and DALYs among men and women of different age groups in China in 2021. by Zhengpeng Li (2322058)

Subjects:

All–age cases and age–standardised incidence, prevalence, mortality, DALYs and corresponding AAPC for RA in China and world in 1990 and 2021. by Zhengpeng Li (2322058)

Subjects: